Outsourcing

The Logistics of Outsourcing Biologics

The trends shaping the growth of the biologics outsourcing industry demand attention.

Outsourcing Still Vital

The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.

Current Trends in Host Cell Protein Detection for Biologics Manufacturing

In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.

Communication is Key in Complex Tech Transfer

May 15, 2023

The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.

Fill/Finish Lessons Learned from COVID-19

May 15, 2023

Can CDMOs apply lessons learned from the COVID-19 pandemic to improve sterile processing?

The Smart Benefit of Digital Systems in Preclinical Studies

May 01, 2023

Preclinical studies specifically benefit from the “smart” drug development trend through deeper data access and analysis.

Ginkgo Bioworks Acquires AAV Capsid Technology and Forms Partnership for Next-Gen CAR-T Cell Therapies

April 14, 2023

Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.

Syngene Utilizes New Innovation in the Manufacturing Value Chain

April 03, 2023

Discussing the Growing Role of CDMOs with Anil Kane (DCAT 2023)

March 29, 2023

Anil Kane, executive director, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, discusses the growing role of CDMOs in the biopharma industry

Illuminating the State of Outsourcing with Stephen Houldsworth (DCAT 2023)

March 27, 2023

Stephen Houldsworth, VP and Head of Platform Management & Marketing at CordenPharma, dives into ongoing trends in the outsourcing space.

Scorpius BioManufacturing Announces New Microbial Capacity and New Interim President

March 22, 2023

In addition to a new interim president, the company is opening new microbial capacity at its San Antonio facility and has plans to construct a commercial-scale facility in Manhattan, Kan.

Outsourcing Still Vital

March 01, 2023

The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.

The Logistics of Outsourcing Biologics

March 01, 2023

The trends shaping the growth of the biologics outsourcing industry demand attention.